Catalog No.
Product Name
Application
Product Information
Citations
-
Purine Nucleoside Analog
2'-Deoxy-N6-(4-methoxybenzyl)adenosine is a purine nucleoside analog that demonstrates significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for research in cancer biology and therapeutic development. This reagent serves as a crucial compound for studying cellular responses to nucleoside analogs and their potential in oncology. -
Purine Nucleoside Analog
1,2-Di-O-acetyl-3,5-di-O-benzyl-D-xylofuranose is a purine nucleoside analog. It exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. The compound's anticancer mechanisms include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research and therapeutic studies. -
Purine Nucleoside Analog
1-(3’-O-[4,4’-Dimethoxytrityl]-alpha-L-threofuranosyl)uridine is a purine nucleoside analog that exhibits significant antitumor activity, specifically targeting indolent lymphoid malignancies. Its primary mechanisms of action include inhibition of DNA synthesis and the induction of apoptosis. This compound is valuable for research applications focused on cancer biology and therapeutic strategies against various malignancies. -
Purine Nucleoside Analog
5’-Deoxy-5’-iodo-2’-O-(2-methoxyethyl)-5-methyluridine is a purine nucleoside analog known for its significant antitumor activity, particularly against indolent lymphoid malignancies. This compound primarily exerts its effects by inhibiting DNA synthesis and inducing apoptosis in cancer cells. It serves as a valuable tool in cancer research, aiding in the exploration of therapeutic strategies and the development of novel anti-cancer agents. -
Purine Nucleoside Analog
2′,3′-Dideoxy-3′-fluoroadenosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanism involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable compound for cancer research. This reagent is useful in studies focused on the therapeutic potential of nucleoside analogs and their roles in cancer treatment strategies. -
Purine Nucleoside Analog
2-Amino-6-chloropurine-9-beta-D-(2’-deoxy-3’,5’-di-O-(p-toluoyl))riboside is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. This compound primarily functions by inhibiting DNA synthesis and promoting apoptosis, making it a valuable tool in cancer research. Its unique structural features also enable exploration of therapeutic strategies targeting purine metabolism in neoplastic cells. -
Cytidine Analog
3’-beta-C-Methylcytidine is a cytidine nucleoside analog that primarily targets DNA methyltransferases. This compound demonstrates significant anti-metabolic and anti-tumor activities, making it a valuable tool in cancer research. It is suitable for studies focused on epigenetic regulation and therapeutic interventions aimed at altering DNA methylation patterns. -
Adenosine Analog
3’-O-(2-Methoxyethyl)-2-aminoadenosine is an adenosine analog that primarily targets adenosine receptors. This compound exhibits significant smooth muscle vasodilatory properties and has demonstrated potential in inhibiting cancer progression. Research applications include studying vascular biology, exploring therapeutic avenues in oncology, and investigating the signaling pathways mediated by adenosine receptors. -
Purine Nucleoside Analog
2′-Deoxy-2-hydrazinyladenosine is a purine nucleoside analog that demonstrates significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanism involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. This compound is suitable for investigating therapeutic approaches in oncology and understanding the molecular pathways involved in tumor cell proliferation and survival. -
Purine Nucleoside Analog
TLR7 agonist 10 is a purine nucleoside analog that functions as a TLR7 activator. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, through mechanisms such as the inhibition of DNA synthesis and the induction of apoptosis. TLR7 agonist 10 is essential for research focused on cancer biology and therapeutic development. -
Purine Nucleoside Analog
3’-Deoxy-O6-methyl inosine is a purine nucleoside analog that demonstrates significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanism involves the inhibition of DNA synthesis, leading to the induction of apoptosis in cancer cells. This compound is valuable for research applications focused on understanding cancer biology and developing novel therapeutic strategies. -
Purine Nucleoside Analog
3’-Deoxy-3’-fluoro-2-thiouridine is a purine nucleoside analog known for its significant antitumor activity. It targets indolent lymphoid malignancies and exerts its effects primarily through the inhibition of DNA synthesis and the induction of apoptosis. This compound serves as a valuable tool in cancer research, enabling studies on therapeutic strategies against various malignancies. -
Purine Nucleoside Analog
6-Chloro-2-iodopurine-9-riboside is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanism involves the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. This compound is valuable for research applications focused on understanding cancer biology and developing targeted therapies. -
Purine Nucleoside Analog
2-Amino-3’-deoxy-3’-fluoroadenosine is a purine nucleoside analog that exhibits significant anticancer activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis. This compound is valuable for research applications focused on cancer biology and the development of novel anticancer therapeutics. -
Purine Nucleoside Analog
3′-Azido-2′,3′-dideoxy-5-hydroxyuridine is a purine nucleoside analog that exerts its effects by inhibiting DNA synthesis, thereby disrupting cellular replication. It demonstrates significant antitumor activity, particularly against indolent lymphoid malignancies, and promotes apoptosis in cancerous cells. This compound is useful in research focused on cancer treatment and the mechanisms of chemotherapeutic agents. -
Purine Nucleoside Analog
5-(Aminomethyl)-2′,3′-O-(1-methylethylidene)-2-thiouridine is a purine nucleoside analog known for its significant antitumor activity. This compound targets indolent lymphoid malignancies through mechanisms such as inhibition of DNA synthesis and induction of apoptosis. It serves as a valuable reagent for cancer research aimed at understanding and developing therapies for lymphoid cancers. -
Adenosine Analog
3',5'-TIPS-N-Ac-Adenosine is an adenosine analog that primarily targets adenosine receptors. This compound exhibits significant smooth muscle vasodilatory activity and has potential applications in inhibiting cancer progression. It is valuable for research related to vascular biology and oncology, facilitating the study of adenosine receptor signaling pathways and their therapeutic implications. -
Purine Nucleoside Analog
5-(Trifluoromethyl)cytidine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanism involves the inhibition of DNA synthesis, which can lead to apoptosis in cancer cells. This compound is valuable for research applications focused on cancer biology and the development of novel therapeutic strategies. -
Purine Nucleoside Analog
2-Methoxy-9-β-D-ribofuranosyl-9H-purine is a purine nucleoside analog that demonstrates significant antitumor activity, particularly against indolent lymphoid malignancies. This compound exerts its anticancer effects primarily through the inhibition of DNA synthesis and the induction of apoptosis in malignant cells. It is utilized in research focused on understanding and developing treatments for various lymphoid cancers. -
Purine Nucleoside Analog
8-Bromo-3'-deoxyguanosine is a purine nucleoside analog known for its capacity to inhibit DNA synthesis. Its primary mechanism involves inducing apoptosis, contributing to its antitumor activity, particularly against indolent lymphoid malignancies. This compound is valuable in cancer research for studying cellular responses and therapeutic strategies in oncology. -
Purine Nucleoside Analog
2′-Deoxy-2′-fluoro-4-deoxy-arabinouridine functions as a purine nucleoside analog. It exhibits significant antitumor activity, particularly effective against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for researchers studying cancer therapeutics and cellular response pathways. -
Purine Nucleoside Analog
3’-Deoxy-3’-fluoro-N6,N6-dimethyladenosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism of action involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. This compound is useful for studying the effects of purine metabolism and the therapeutic potential of nucleoside analogs in oncology. -
Purine Nucleoside Analog
2-Chloro-2'-deoxy inosine is a purine nucleoside analog known for its antitumor properties. It effectively targets indolent lymphoid malignancies by inhibiting DNA synthesis and inducing apoptosis in cancer cells. This compound is primarily utilized in research applications focused on cancer biology and the development of therapeutic strategies against lymphoid cancers. -
Purine Nucleoside Analog
5’-O-Benzoyl-2’-O,4’-C-methyleneuridine is a purine nucleoside analog that exhibits significant antitumor activity by targeting indolent lymphoid malignancies. Its anticancer mechanisms primarily involve the inhibition of DNA synthesis and the induction of apoptosis. This compound is valuable for research applications focused on cancer therapeutics and the biochemical pathways associated with cell proliferation and survival. -
Purine Nucleoside Analog
3’-O-Acetyl-2’-deoxyuridine is a purine nucleoside analog that interferes with DNA synthesis, offering potential therapeutic avenues in cancer research. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the induction of apoptosis, making it a valuable tool for investigating cancer biology and developing new therapeutic strategies. -
Purine Nucleoside Analog
5-O-Benzoyl-1,2-di-O-isopropylidene-3-keto-alpha-D-xylofuranoside is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism of action involves the inhibition of DNA synthesis and the promotion of apoptosis. This compound is valuable for researchers investigating targeted therapies in cancer treatment. -
Adenosine Analog
8-(Methylamino)adenosine is an adenosine analog that primarily targets adenosine receptors. This compound exhibits significant vasodilatory effects on smooth muscle and has been demonstrated to possess anti-cancer properties by inhibiting tumor progression. It is utilized in various research applications related to vascular biology and oncology. -
Purine Nucleoside Analog
2'-Deoxy-8-methylthioguanosine is a purine nucleoside analog that exhibits significant antitumor activity against indolent lymphoid malignancies. Its primary mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. This compound is suitable for studies focused on therapeutic interventions in hematological cancers and the exploration of nucleoside analogs in chemotherapy. -
Cytidine Analog
3’-O-(2-Methoxyethyl)-5-methylcytidine is a nucleoside analog targeting DNA methyltransferases. This compound exhibits potential anti-metabolic and anti-tumor activities, making it valuable in cancer research and epigenetic studies. It is particularly useful for investigating the role of DNA methylation in gene regulation and cellular processes. -
Purine Nucleoside Analog
1-(alpha-L-Threofuranosyl)cytosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable compound for cancer research and therapeutic applications. This compound is a key tool for studies focused on the mechanisms of nucleoside analogs in cancer treatment strategies. -
Purine Nucleoside Analog
N1-Methyl-N3-[(2S)-2-(t-butoxycarbonyl)amino-3-(t-butoxycarbonyl)]propylpseudouridine is a purine nucleoside analog primarily targeting DNA synthesis. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, through mechanisms that include the inhibition of DNA replication and the induction of apoptosis. Its applications in cancer research make it a valuable tool for studying nucleoside analog effects in therapeutic interventions. -
Purine Nucleoside Analog
5'-Protected 2,2'-anhydrouridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action primarily involve the inhibition of DNA synthesis and the induction of apoptosis. This compound is an essential tool for research focused on cancer biology and therapeutic development, providing insights into nucleoside metabolism and therapeutic strategies. -
Adenosine Analog
3'-β-C-Ethynyl-N6,N6-dimethyladenosine is an adenosine analog with significant implications in vascular research and oncology. This compound serves as a smooth muscle vasodilator and has demonstrated potential in inhibiting cancer progression. Additionally, it functions as a click chemistry reagent due to its alkyne group, allowing for copper-catalyzed azide-alkyne cycloaddition (CuAAC) with azide-containing molecules, making it a valuable tool for bioconjugation and labeling applications in chemical biology. -
Purine Nucleoside Analog
2’-β-C-Methyl-6-azauridine is a purine nucleoside analog that exerts its effects primarily through the inhibition of DNA synthesis. This compound demonstrates significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the induction of apoptosis, making it a valuable reagent for cancer research and therapeutic studies focused on lymphoid tumors. -
Purine Nucleoside Analog
2’-O-Acetyl-3’-azido-5’-O-(4-methylbenzoyl)-3’-deoxyuridine is a purine nucleoside analog that demonstrates significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanism involves the inhibition of DNA synthesis and the induction of apoptosis, facilitating its efficacy in cancer research. Additionally, this compound serves as a versatile click chemistry reagent due to its azide group, enabling copper-catalyzed azide-alkyne cycloaddition (CuAAc) and strain-promoted alkyne-azide cycloaddition (SPAAC) with alkyne-containing molecules, DBCO, or BCN groups. This makes it a valuable tool for bioconjugation and molecular labeling studies. -
Purine Nucleoside Analog
3’-Deoxy-3’-fluoro-5-methyl-xylo-uridine is a purine nucleoside analog primarily involved in inhibiting DNA synthesis. It exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, by inducing apoptosis and disrupting cellular proliferation. This compound is valuable for research applications focused on cancer biology and therapeutic development. -
Purine Nucleoside Analog
2'-Deoxy-N6-cyclopentyladenosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. This compound is utilized in research applications aimed at understanding cancer biology and developing novel therapeutic strategies. -
Purine Nucleoside Analog
7-Methyl wyosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. This compound is utilized in research applications focused on cancer therapy and the study of nucleoside interactions within cellular processes. -
Purine Nucleoside Analog
2′-Deoxy-2-iodoadenosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis. This compound is valuable for research applications in cancer biology and therapeutic development targeting various malignancies. -
Purine Nucleoside Analog
8-Azaguanosine is a purine nucleoside analog that exhibits significant anticancer activity, particularly against indolent lymphoid malignancies. Its primary mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis. This compound is utilized in research aimed at understanding and developing targeted therapies for various hematological malignancies. -
Purine Nucleoside Analog
3’-O-MOE-A(Bz)-2’-CED-phosphoramidite is a purine nucleoside analog that impedes DNA synthesis and induces apoptosis, making it a valuable tool in cancer research. This compound exhibits significant antitumor activity against indolent lymphoid malignancies, facilitating studies on mechanisms of tumor growth inhibition. It is suitable for applications in the development of therapeutic strategies and understanding purine metabolism in cancer cells. -
Purine Nucleoside Analog
3',5'-Di-O-acetylthymidine is a purine nucleoside analog that exhibits significant antitumor activity against indolent lymphoid malignancies. Its primary mechanisms include the inhibition of DNA synthesis and the induction of apoptosis. This compound is valuable for research into cancer therapeutics and the modulation of nucleoside metabolism in cancer cells. -
Purine Nucleoside Analog
3’-Deoxy-3’-fluoro-5-methyluridine is a purine nucleoside analog with potent antitumor activity. This compound primarily targets indolent lymphoid malignancies through mechanisms that include the inhibition of DNA synthesis and the induction of apoptosis. It is a valuable tool for researchers investigating cancer biology and therapeutic strategies in oncology. -
Purine Nucleoside Analog
N2-iso-Butyroyl-2'-fluoro-2'-deoxyarabinoguanosine is a purine nucleoside analog that exerts antitumor activity primarily against indolent lymphoid malignancies. Its mechanism of action involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. This compound is useful for studying the effects of nucleoside analogs in various cancer models. -
Purine Nucleoside Analog
5'-O-DMT-2-thio-2'-dU-3'-phosphoramidite is a purine nucleoside analog that acts as a potent inhibitor of DNA synthesis. It exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, by inducing apoptosis and disrupting nucleotide incorporation during DNA replication. This compound is essential for research into cancer therapeutics and the development of novel DNA-targeting strategies. -
Purine Nucleoside Analog
2-Methoxy-2'-deoxy-2'-fluoro-beta-D-arabinoadenosine is a purine nucleoside analogue known for its antitumor properties. This compound exhibits significant activity against indolent lymphoid malignancies, primarily through the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. It is a valuable tool for research applications focused on cancer biology and therapeutic development. -
Purine Nucleoside Analog
3’-Deoxy-2’-thiouridine is a purine nucleoside analog that exhibits significant antitumor activity. This compound primarily targets indolent lymphoid malignancies through mechanisms such as the inhibition of DNA synthesis and the induction of apoptosis. It is a valuable reagent for researchers investigating cancer biology and therapeutic strategies targeting nucleoside metabolism. -
Adenosine Analog
N6-(3-Trifluoromethylbenzyl)-2’-C-methyl adenosine is an adenosine analog that primarily acts on adenosine receptors. This compound demonstrates smooth muscle vasodilatory properties and has potential applications in inhibiting cancer progression. Its structural modifications enhance its affinity and selectivity, making it a valuable reagent for research in vascular biology and oncology. -
Purine Nucleoside Analog
6-(2-Furanyl)-9-β-D-ribofuranosyl-9H-purine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanism involves the inhibition of DNA synthesis, leading to the induction of apoptosis in cancer cells. This compound is valuable for research applications focused on cancer therapeutics and the study of nucleoside metabolism. -
Purine Nucleoside Analog
5’-Deoxy-5’-(4-morpholinyl)thymidine is a purine nucleoside analog that demonstrates significant antitumor activity, particularly in indolent lymphoid malignancies. Its primary mechanism involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound can be utilized to explore therapeutic strategies and uncover insights into the molecular mechanisms of tumor growth and response to treatment.
